Clinical Trial Update: Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial evaluating the combination of radiofrequency ablation and cytokine-induced killer cells for ovarian cancer; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Cytokine-induced killer cells

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Ovarian Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING